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1. INTRODUCTION 
Lectins are proteins which can act as cell agglu- 
tinins and, in some cases, can induce lymphocyte 
transformation [1-3]. These properties are related 
to their ability to act as sugar-recognizing proteins. 
A classification of lectins, based on their sugar spe- 
cificity, has been proposed [4]. Phytohemagglutinin 
(PHA), the lectin from Phaseolus vulgaris (red kid- 
ney beans), possesses a large sugar binding site 
which enables recognition of complex oligosaccha- 
ridic structures at the cell surface [5-7]. There are 
conflicting reports concerning the ability of PHA to 
specifically recognize monosaccharides [5-14]. 
Furthermore, it has been claimed that the lectin 
does not show specificity towards agglutination of 
human erythrocytes [4,12]. 
Here, we have investigated the specificity of PHA 
towards agglutination of the major human erythro- 
cyte blood groups using the technique in [15]. Our 
results show that PHA agglutinates preferentially 
human erythrocytes of group A. A series of mono- 
saccharides have been used to assess the structural 
requirements for monosaccharides to inhibit the 
agglutination reaction. Results show that the lectin 
can distinguish between opposite configuration or 
substitution at positions 2 and 4 of the pyranose 
ring. 
Abbreviations: PHA phytohemagglutinin; PBSA, phos- 
phate-buffered saline-bovine s rum albumin 
2. MATERIALS AND METHODS 
Phytohemagglutinin prepared according to [16], 
was purified on a Sepharose-thyroglobulin column 
as in [17]. The lectin appeared to be homogeneous 
by polyacrylamide gel electrophoretic analysis at 
pH 9.3 and 413. Mono-, di-, tri- and tetrasaccharides 
were obtained from Sigma (St Louis MO) or from 
PL-Biochemicals (Milwaukee WI). l-Amino-l-de- 
oxy-D-galactopyranose wasprepared as in [18]. 
Blood obtained by venipuncture was centrifuged 
(10 min/600 x g), plasma and buffy coat were 
removed and the erythrocyte suspension was dilu- 
ted (1:10) with Dulbecco's phosphate-buffered sa- 
line containing 0.5% (w/v) bovine serum albumin 
(PBSA) and centrifuged. An additional wash with 
PBSA was performed and the red blood cells were 
diluted to 2 x 106/ml. 
Agglutination assays were performed according 
to [15]. Various amounts of PHA (1 mg/ml) in 
phosphate-buffered saline were deposited, in du- 
plicate, in the wells of a 'tissue cluster' plastic box 
(Costar, Cambridge MA) and the volume was 
completed to 0.1 ml with PBSA. Erythrocytes (2 x 
105 cells) in PBSA (0.1 ml) where then added. The 
box was gently agitated (wrist-action shaker) over- 
night, at 4°C. The cells were carefully aspirated 
with a short (14.5 cm) Pasteur pipette and deposited 
into a spectrophotometric cuvette. Volume was 
completed to 1 ml by addition of PBSA (0.8 ml). 
Readings were performed at 550 nm. An interval of 
-3  s elapsed between dilution and absorbance 
readings. For inhibition of agglutination, PHA 
(8-10 #g) was added to individual wells of the tissue 
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culture dish, followed by addition of a 0.3- 1 .O M 
solution of saccharide in PBSA. The volume was 
completed to 0.1 ml and the mixture was left, under 
agitation, for 30 min at 4°C. Red blood cells (group 
A) were then added (2 x IO5 cells) and incubation 
and readings were performed as above. 
XD. 
.o, . 
Fig.1. Upper: Turbidimetric measurements of human 
erythrocyte suspensions (2 x lo5 cells/ml) as a function 
of increasing amounts of PHA, in 0.2 ml total vol. The 
mixture was incubated overnight at 4°C in a multi-well 
plastic dish, each well was diluted to 1.0 ml before read- 
ings were done. The graphs represent the effect of PHA 
on the agglutination of human cells of group A (m), group 
0 (o) and group B (0). Lower: Various amounts of test 
saccharides were added to a solution of PHA (8-10 pg). 
The mixture was incubated for 30 min at 4°C and human 
erythrocytes (type A) (2 x lo5 cells) were added: final 
vol. 0.21 ml. Conditions of incubation and readings were 
done as above. The graph represents the effect of 2-ace- 
tamido-2-deoxy-D-galactose (m), D-galactose (o), 2-ace- 
tamido-2-deoxy- D-glucose (0) and 2-amino-2-deoxy- 
D-galactose (v) on PHA-induced erythroagglutination. 
2-Acetamido-2-deoxy-D-galactose 
D-Galactose 
1 -Amino- 1 -deoxy-P-D-galactopyranose 
D-Fucose 
D-Glucose 
D-Fructose 
D-Mannose 
2-Amino-2-deoxy-D-galactose 
2-Amino-2-deoxy-D-glucose 
2-Acetamido-2-deoxy-D-glucose 
I-0-Methyl-P-D-galactopyranose 
Lactose 
Lactulose 
Raftinose 
Stachyose 
The test sugar was added to a solution of PHA (8-10 pg) 
in PBSA and incubations were performed for 30 min at 
4°C. Human (group A) erythrocytes (2 X IO5 cells) were 
added, the volume was completed to 0.2 ml and incuba- 
tion was continued overnight at 4°C. The mixture was 
diluted to 1.0 ml and turbidimetric readings at 550 nm 
Ordinate represents readings in Asso units. were performed 
3. RESULTS 
The results of human erythrocyte agglutination 
are presented in the upper part of fig. 1. PHA ag- 
glutinated erythrocytes from the major human 
blood groups but was more efficient towards cells of 
group A. Concentrations of lectin necessary to bring 
50% agglutination (absorbance units) of the cells 
were 8 pg (group A), 12 PLg (group 0) and 22 pg 
(group B), whereas complete agglutination was ob- 
served with 15 pg (group A), 40 PLg (group 0) and 
40-50 pg (group B) of lectin. The effect of various 
saccharides on the agglutination reaction is shown 
in the lower part of fig.1. Results show that, in 
addition to 2-acetamido-2-deoxy-D-galactose, 
D-galactose is a good inhibitor of the agglutination 
Table 1 
Inhibition of PHA-induced agglutination of human 
erythrocytes (group A) by various sugars 
Sugar added Quantity of 
sugar to produce 
a 50% inhibition 
of agglutination 
(pmol) 
S-10 
22 
30 
30 
> 50 
> 50 
> 50 
> 50 
> 50 
> 50 
> 50 
> 75 
> 75 
> 75 
> 75 
30 
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reaction. In this typical experiment, 2-acetami- 
do-2-deoxy-D-glucopyranose and 2-amino-2-deo- 
xy-galactopyranose are inactive. The effects of a 
series of saccharides on the agglutination reaction is 
shown in table 1 where the no. pmol sugar necessary 
to produce a 50% inhibition (absorbance units) of 
agglutination of human group A erythrocytes are 
tabulated. There was no inhibition of agglutination 
by monosaccharides such as D-glucose, D-fructose, 
D-mannose, I-0-methyl+D-galactopyranose, 2- 
amino-2-deoxy-D-glucose, 2-amino-2-deoxy-D-ga- 
lactose and 2-acetamido-2-deoxy-D-glucose. Di-, 
tri- and tetrasaccharides were also tested (table 1). 
Lactose (O-P-D- galactopyranosyl- (l-+4)-D-gluco- 
pyranose), lactulose (O-p-D-galacto-pyranosyl-( l- +4) 
-D-fructofuranose), raflinose (O-a-D-glucopyranosyl- 
(145)-D-fructofuranose) and stachyose (O-o-D- 
galactopyranosyl-( l- +6)-cY-D-galactopyranosyl-( l-6) 
-a-D-glucopyranosyl-( l-+5)-P-D-fructofuranose) were 
not inhibitors. It is interesing to compare the in- 
hibitory effect of l-amino- l-deoxy-&D-galacto- 
pyranose and 2-amino-2-deoxy-D-galactose. 
Whereas the former was inhibitor of agglutination, 
the latter had no effect. 
4. DISCUSSION 
The technique of inhibition of lectin-induced 
agglutination of erythrocytes, has been used for 
topological examination of the sugar binding site 
and specificity of lectins (reviewed in [4]). Kornfeld 
and Komfeld [5,6] have isolated a glycopeptide 
from human erythrocytes and shown that it in- 
hibits PHA-induced agglutination of human 
erythrocytes. They proposed the structure O-/&D- 
galactopyranosyl-( +4)-2-acetamido-2-deoxy-D- 
glycopyranosyl-( l-+2)-D-manno-pyranose for this 
saccharide. Toyoshima et al. [7] used glycopeptides 
derived from porcine thyroglobulin to study in- 
hibition of PHA-induced stimulation of human 
lymphocytes and agglutination of human erythro- 
cytes. They concluded that the determinant sugar 
had the same structure as proposed in [5,6]. Kaif 
and Osawa [8] have synthesized the trisaccharide 
mentioned above and shown that it inhibits PHA 
agglutination of human erythrocytes. These authors 
have also studied the effect of chain shortening. 
Whereas, the disaccharide O-P-D-galactopyran- 
osyl-( l-+4)-2-acetamido-2-deoxy-D-glucopyranose 
was an effective inhibitor, 0-P-D-2-acetamido- 
2-deoxy-D-glucopyranose-( l-+2)-D-mannopyra- 
nose was - 3-times less active than the trisaccharide. 
The above results would suggest hat the sugar 
binding site of PHA can accommodate a large oli- 
gosaccharidic structure bearing, at least, the 
D-gal-D-glcNAc structure. However, there are 
contradictory reports in the literature with respect 
to the ability of PHA to recognize monosaccharides. 
Komfeld and Kornfeld [5,6] and Toyoshima et al. 
[7] have presented evidence that simple sugars were 
weakly recognized by PHA. In contrast, Borberg et 
al. [9,11], Pogo [lo] and Kay [ 141 have shown that 
2-acetamido-2-deoxy-D-galactose interferes with 
the biological activities of PHA. 
Here, we have used a PHA preparation which 
migrates as a single band on electrophoretic gels. 
Agglutination assays (or inhibition) was performed 
overnight at 4°C. This approach resulted in repro- 
ducible spectrophotometric determinations. 
Our results show that PHA selectively agglutin- 
ates erythrocytes of the major human blood groups. 
Group A red blood cells are best agglutinated by 
the lectin, group 0 is less strongly agglutinated and, 
group B, the least of the 3. Our data confirm the 
reports that 2-acetamido-2-deoxy-D-galactose can 
serve as an effective inhibitor of PHA-induced ag- 
glutination of human erythrocytes but extend the 
studies to a determination of the requirements at 
positions 1,2,4 and 6 of the pyranose ring. We ob- 
served that 8- 10 pmol2-acetamido-2-deoxy-D-ga- 
lactose was sufficient to inhibit the agglutination 
reaction by 50% in terms of absorbance units. When 
position 2 of the galactopyrasone ring bears a hy- 
droxyl function, the sugar (D-galactose) is 
-_-times less active than its acetamido analog. 
Replacement of the hydroxyl function at position 6 
by a hydrogen atom diminishes but does not abolish 
haptenic activity. The sugare (D-fucose) is 
3-4-times less effective than 2-acetamido-2-deo- 
xy-D-galactose. Interestingly, when position 2 is 
substituted by a positively charged amino group 
(2-amino-2-deoxy-D-galactose), haptenic activity is 
lost. This is not the case for position 1 where the 
hydroxyl group of the hemiacetal function can be 
replaced by an amino group. Configuration at po- 
sition 4 appears to be of great importance. Epime- 
risation at this position yields the non haptenic 
D-glucose and 2-acetamido-2-deoxy-D-glucose. 
D-mannose, which is epimeric with D-galactose at 
positions 2 and 4, was not active. Similarly, D-fruc- 
31 
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tose was inactive. Di, tri- and tetrasaccharides bear- 
ing the sequence D-galactose-D-glucose, D-ga- 
lactose-D-fructose, D-glucose-D-fructose, or 
D-galactose-D-galactose-D-glucose-D-fructose 
were not active. 
It would appear that PHA possesses, at its sugar 
binding site, at least one locus which recognizes and 
discriminates pecifically between the nature and 
configuration of substituents at positions 2 and 4 of 
the pyranose ring. Our data do not allow an assess- 
ment of the conformational requirements for posi- 
tion 3. The finding that I-0-methyl-/3-D-galacto- 
pyranose was not inhibitor was unexpected in view 
of the fact that in the case of other lectins, the 
l-O-methyl derivatives of sugars can usually act as 
haptens 141. The lectin BS II from Bandeiraea sim- 
plicifotia can discriminate between the two anome- 
ric 0-methyl-D-glucopyranosides 1191 but it re- 
mains to be seen if PHA can show the same speci- 
ficity towards the O-methyl derivatives of D-galac- 
tose. 
Our findings that PHA can selectively agglutinate 
erythrocytes of the major human blood groups is in 
agreement with the observed specificity of the lectin 
towards monosaccharides. The terminal sugars of 
the carbohydrates moieties of the major human 
blood groups are: 0-cY-2-acetamido- 2 deoxy-D-ga- 
lactopyranosyl-( 143)-/3-D-galactopyranosyl (group 
A); 0-a-D-galactopyranosyl-( 1+3)-/3-D-galacto- 
pyranosyl (group B); and 0-/3-D-galacto- 
pyranosyl-( l -3)-/3-2-acetamido-2-deoxy-D-gluco- 
pyranosyl (group O(H) ) [4,20]. These structural 
relationships can, in part, explain the specificity 
of PHA towards selective agglutination of human 
erythrocytes as reported in this study. Additional 
factors such as the size of the lectin sugar binding 
site and the number of sugar residues which an be 
accommodated, remain to be investigated. 
Work is in progress in our laboratory to label the 
sugar binding of PHA with suitable derivatives of 
D-galactose. 
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